Pure Global

Predictors of Readmission in Patients Undergoing PNL - Trial NCT05852483

Access comprehensive clinical trial information for NCT05852483 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Completed. The study focuses on Kidney Stone. Target enrollment is 161 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05852483
Completed
Trial Details
ClinicalTrials.gov โ€ข NCT05852483
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Predictors of Readmission in Patients Undergoing PNL
Perioperative Predictors of Postoperative Readmission Among Patients Undergoing Percutaneous Nephrolithotomy

Study Focus

Kidney Stone

Observational

Sponsor & Location

Assiut University

Assiut, Egypt

Timeline & Enrollment

N/A

Apr 01, 2022

Dec 01, 2022

161 participants

Primary Outcome

comparison between readmitted and non readmitted regarding readmission risk factors

Summary

To identify predictors of patients postoperative readmission after PNL

ICD-10 Classifications

Kidney dialysis
Small kidney, unspecified
Disorder of kidney and ureter, unspecified
Injury of kidney
Unspecified kidney failure

Data Source

ClinicalTrials.gov

NCT05852483

Non-Device Trial